Charpin C, Devictor B, Bonnier P, Andrac L, Lavaut M N, Allasia C, Piana L
Department of Pathology, Hôpital de la Timone, Marseille, France.
J Pathol. 1993 Aug;170(4):463-70. doi: 10.1002/path.1711700410.
Immunocytochemical assays of cathepsin D were assessed in a series of breast carcinomas (n = 257) using monoclonal M1G8 anti-total cathepsin D and the avidin-biotin-peroxidase complex. Cathepsin immunoreactivity was compared in frozen and paraffin sections. All tumours were anti-cathepsin-positive. Positive staining was observed in carcinoma and stromal cells and in the extracellular matrix. The amount of immunodetectable cathepsin in tissue was measured by computer-assisted image analysis (SAMBA 2005). Both the percentage of immunostained tumour surface and the mean optical densities were processed as continuous variables for statistical analysis and correlated with prognostic factors. It was shown that cathepsin D was independent of the tumour size, the lymph node status, hormone receptors, and pHER-2/neu overexpression. Cathepsin was significantly correlated with anti-EGFR (P = 0.012) and Ki67 (P = 0.002) immunoreactivity, tumour grade (P = 0.032), vascular invasion (P = 0.0081), proliferation index (P = 0.0045), and, to a lesser extent with AgNORs (P = 0.0504) and the degree of hyperploidy (P = 0.057). Tissue fixation and paraffin embedding significantly decreased cathepsin immunoreactivity. These results show that cathepsin D is not a totally independent prognostic factor in breast carcinomas.
使用单克隆M1G8抗组织蛋白酶D和抗生物素蛋白-生物素-过氧化物酶复合物,对一系列乳腺癌(n = 257)进行组织蛋白酶D的免疫细胞化学分析。比较了冷冻切片和石蜡切片中的组织蛋白酶免疫反应性。所有肿瘤均为抗组织蛋白酶阳性。在癌细胞、基质细胞和细胞外基质中均观察到阳性染色。通过计算机辅助图像分析(SAMBA 2005)测量组织中可免疫检测到的组织蛋白酶的量。将免疫染色肿瘤表面的百分比和平均光密度作为连续变量进行统计分析,并与预后因素相关联。结果表明,组织蛋白酶D与肿瘤大小、淋巴结状态、激素受体和pHER-2/neu过表达无关。组织蛋白酶与抗表皮生长因子受体(EGFR)(P = 0.012)和Ki67(P = 0.002)免疫反应性、肿瘤分级(P = 0.032)、血管侵犯(P = 0.0081)、增殖指数(P = 0.0045)显著相关,与核仁组成区嗜银蛋白(AgNORs)(P = 0.0504)和超二倍体程度(P = 0.057)的相关性较小。组织固定和石蜡包埋显著降低了组织蛋白酶的免疫反应性。这些结果表明,组织蛋白酶D在乳腺癌中不是一个完全独立的预后因素。